Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1986 4
1987 4
1988 9
1989 8
1990 2
1991 1
1992 3
1993 2
1994 2
1995 6
1996 3
1997 7
1998 3
1999 4
2000 2
2001 2
2002 1
2003 3
2004 3
2005 10
2006 6
2007 5
2008 3
2009 1
2010 2
2011 2
2012 2
2013 2
2015 2
2016 12
2017 4
2018 4
2019 6
2020 17
2021 17
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Results by year
Filters applied: . Clear all
Page 1
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R. Marzano AV, et al. Among authors: crimi n. J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7. J Eur Acad Dermatol Venereol. 2019. PMID: 30451325 Free article.
Bronchiectasis and asthma: a dangerous liaison?
Crimi C, Ferri S, Crimi N. Crimi C, et al. Among authors: crimi n. Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):46-52. doi: 10.1097/ACI.0000000000000492. Curr Opin Allergy Clin Immunol. 2019. PMID: 30516546 Review.
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
Bongiorno MR, Crimi N, Corrao S, Allotta A, Arena A, Brusca I, Heffler E, Malara G, Milioto M, Pistone G, Porto M, Raia E, Valenti G. Bongiorno MR, et al. Among authors: crimi n. Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6. Ann Allergy Asthma Immunol. 2016. PMID: 27720581 Review. No abstract available.
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
Nolasco S, Crimi C, Pelaia C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta D, D'Amato M, Macchia L, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Campisi R, Valenti G, Vatrella A, Crimi N. Nolasco S, et al. Among authors: crimi n. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4371-4380.e4. doi: 10.1016/j.jaip.2021.08.004. Epub 2021 Aug 19. J Allergy Clin Immunol Pract. 2021. PMID: 34419679
Adherence to omalizumab: A multicenter "real-world" study.
Campisi R, Crimi C, Intravaia R, Strano S, Noto A, Foschino MP, Valenti G, Viviano V, Pelaia C, Ricciardi L, Scichilone N, Crimi N. Campisi R, et al. Among authors: crimi n. World Allergy Organ J. 2020 Feb 12;13(2):100103. doi: 10.1016/j.waojou.2020.100103. eCollection 2020 Feb. World Allergy Organ J. 2020. PMID: 32082464 Free PMC article.
Exhaled bronchial cysteinyl leukotrienes in allergic patients.
Failla M, Crimi N, Vancheri C. Failla M, et al. Among authors: crimi n. Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):25-31. doi: 10.1097/ACI.0b013e328012c570. Curr Opin Allergy Clin Immunol. 2007. PMID: 17218807 Review.
Asthma control and bronchodilator response.
Heffler E, Crimi N. Heffler E, et al. Among authors: crimi n. Respir Med. 2016 Jul;116:109. doi: 10.1016/j.rmed.2016.05.013. Epub 2016 May 15. Respir Med. 2016. PMID: 27211114 Free article. No abstract available.
Omalizumab Treatment of Vernal Keratoconjunctivitis.
Heffler E, Picardi G, Liuzzo MT, Pistorio MP, Crimi N. Heffler E, et al. Among authors: crimi n. JAMA Ophthalmol. 2016 Apr;134(4):461-3. doi: 10.1001/jamaophthalmol.2015.5679. JAMA Ophthalmol. 2016. PMID: 26795360 No abstract available.
165 results